Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$6,815,161
+$1,580,750 QoQ
Shares Held
5,682
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#1,489
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversified Enterprises, LLC holds $20,838,520 across 11 Drug Manufacturers - General names. LLY ranks #1 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,682 | $6,815,161 | |
| 2 | JNJ |
Johnson & Johnson
|
17,605 | $4,471,141 | |
| 3 | ABBV |
AbbVie Inc.
|
12,729 | $3,203,125 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,584 | $1,874,044 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
16,834 | $969,975 | |
| 6 | AZN |
Astrazeneca PLC
|
4,654 | $882,491 | |
| 7 | PFE |
Pfizer Inc
|
31,160 | $750,332 | |
| 8 | AMGN |
Amgen Inc
|
1,842 | $667,025 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,815,161 | 5,682 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $5,234,411 | 5,691 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,031,104 | 5,612 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $3,521,245 | 4,615 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $3,616,239 | 4,639 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $3,830,570 | 4,638 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,138,952 | 4,066 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,497,691 | 3,948 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||